Greenwich LifeSciences, Inc. (GLSI)

NASDAQ: GLSI · USD

$18.4

+0.98 (+5.6%)· Recorded snapshot

Market cap	270.1M
Net income (ttm)	-22.5M
EPS (ttm)	-$1.58
Shares out	14.7M
Volume	110,081
Beta	1.46

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -22.5M
EPS (ttm): -$1.58
Market cap: 270.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-986.3

P25 n/aP50 n/aP75 n/a

ROIC-621.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All GLSI indicators

Market & fundamental data

Available fields

176

Groups with data

Currency

USD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001799788
Company name	Greenwich LifeSciences, Inc.
Country	United States
Country code	US
CUSIP number	396879108
Earnings date	2026-11-13
Earnings time	amc
Employees	8
Employees change	1
Employees growth	14.29%
Enterprise value	$261.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2020-09-25
Is primary listing	Yes
Is SPAC	No
ISIN number	US3968791083
Last 10-K release date	2026-06-01
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$270.1M
Market cap category	Micro-Cap
Next earnings date	2026-11-13
Options	No
Price	$18.40
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	GLSI
U.S. state	Texas
Website	https://greenwichlifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-8.58%
FCF / EV yield	-5.06%
FCF yield	-4.88%
P/B ratio	82.03x
Price / tangible book value	82.08x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-2.8M
ROA	-235.98%
ROA (5Y)	-105.48%
ROCE	-726.9%
ROE	-986.32%
ROE (5Y)	-734.23%
ROIC	-621.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$890
EBIT	$-22.7M
EBITDA	$-22.7M
EPS	$-1.58
FCF per share	$-0.85
Financing cash flow	$18.2M
Free cash flow	$-12.5M
Free cash flow minus SBC	$-19.2M
Net cash flow	$5.8M
Net income	$-22.5M
Operating cash flow minus SBC	$-19.2M
Operating income	$-22.7M
Stock-based compensation	$6.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$0.21
Debt / equity	0
Long-term assets	$0
Long-term liabilities	$0
Net cash (debt)	$8.9M
Net cash / market cap	3.47%
Net cash growth	184.03%
Net debt / equity	-2.85
Piotroski F-Score	1
Shareholders' equity	$3.1M
Tangible book value	$3.1M
Tangible book value per share	$0.21
Total assets	$8.9M
Total cash	$8.9M
Total debt	$0
Total liabilities	$5.8M
WACC	12.26%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$8.9M
Current liabilities	$5.8M
Current ratio	1.54
Net working capital	$-5.8M
Quick ratio	1.54
Working capital	$3.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-7.79%
Dividend yield	0%
Shareholder yield	-7.79%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$19.95
1D price change	5.63%
1W price change	12.19%
1W total return	12.19%
1Y price change	86.11%
1Y return CAGR	86.19%
1Y total return	86.11%
20-day SMA	$16.25
200-day SMA	$21.65
3M price change	35.57%
3M total return	35.57%
3Y price change	113.85%
3Y return CAGR	28.83%
3Y total return	113.85%
50-day SMA	$16.68
50-day SMA vs 200-day SMA	50under200
52-week high	$34.10
52-week high date	2026-01-27
52-week low	$7.78
52-week low date	2025-11-24
5Y price change	-47.58%
5Y return CAGR	-12.12%
5Y total return	-47.58%
6M price change	-24.05%
6M total return	-24.05%
All-time high	$158.07
All-time high date	2020-12-09
All-time low	$3.26
All-time low date	2020-11-04
Average true range (ATR)	$1.34
Average volume	133.2K
Beta (1Y)	2.99
Beta (2Y)	1.98
Beta (5Y)	1.46
Change from 52-week high	-46.04%
Change from 52-week low	136.5%
Change from all-time high	-88.47%
Change from all-time low	458.55%
Change from open	6.17%
Day's gap	-0.52%
Dollar volume	$2M
High price	$18.40
Low price	$17.32
Monthly RSI	51.88
Open price	$17.33
Position in 52-week range	100%
Premarket change	-4.99%
Premarket close	$17.42
Premarket price	$16.55
Premarket volume	683
Previous close	$17.42
Price vs 150-day SMA	-8.69%
Price vs 20-day SMA	12.15%
Price vs 200-day SMA	-15.84%
Price vs 50-day SMA	9.25%
Relative volume	0.83
Return from IPO open	203.13%
Return from IPO price	203.13%
RSI	58.89
Sharpe ratio	1.07
Sharpe ratio (3Y)	0.7
Sharpe ratio (5Y)	0.18
Sortino ratio	1.71
Sortino ratio (3Y)	1.19
Sortino ratio (5Y)	0.36
Volume	110.1K
Weekly RSI	50.23
YTD price change	-13.28%
YTD total return	-13.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7.6M
Float percentage	52.09%
Shares change (QoQ)	0.38%
Shares change (YoY)	7.79%
Shares held by insiders	47.91%
Shares held by institutions	11.65%
Shares outstanding	14.7M
Short % of float	20.68%
Short % of shares	10.77%
Short ratio	13.7 days

Deeper analysis on GLSI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this GLSI report

Is a complete GLSI research report available?

No complete published report is available for Greenwich LifeSciences, Inc. (GLSI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Greenwich LifeSciences, Inc. (GLSI)

Price

Financial snapshot

Fair-value bridge

Latest news · GLSI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GLSI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GLSI

Frequently asked questions